Skip to content

REDUNING, a kind of traditional chinese medicine injections, in the treatment of influenza high fever: A randomized controlled clinical trial

REDUNING, a kind of traditional chinese medicine injections, in the treatment of influenza high fever: A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13004045
Enrollment
Unknown
Registered
2013-12-26
Start date
2013-12-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

test group:REDUNING injection and Phosphate oseltamivir simulation caps
control group:REDUNING simulation injection and Phosphate oseltamivir caps

Sponsors

Tianjin University of Traditional Chinese Medcine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients who are accordance with influenza high fever diagnostic standards; 2. patients who are accordance with the TCM syndrome of toxic heat invading lung; 3. the result of influenza virus antigen detection kit is positive; 4. patients whose temperature under armpit >=38.5 degree C; 5. patients who are in the 18-25 age bracket; 6. patients whose course of disease is within 48 hours; 7. patients who muse be voluntary to the trail and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. severe flu patients who are in accordance with "Influenza diagnosis and treatment guidelines (2011 edition) issued by Office of the Ministry of Health; 2. patients who are accompanied with Chronic respiratory disease, acutely paroxysmal phase of chronically asthmatic bronchitis, pneumonia, pharyngo conjunctivitis, suppurative tonsillitis; 3. patients whose WBC of routine blood test is greater than the upper limit of normal, or N%>=75%; 4. patients who are accompanied with heart, liver and kidney disease, hematological system disease and metabolic diseases (such as diabetes, Thyroid disease, adrenal diseases) and cancer; 5. immune deficiency disease or use of immunosuppressive drugs or corticosteroids in nearly 3 months; 6. women who will be pregnancy, or gravida, or during lactation; 7. patients who are allergic constitution, As a general rule, these patients are allergic to any two or more types of medication or food; 8. patients who have taken part in any other clinical trails in recent 3 months; 9. people who is a mental patient, or has incapacity of know himself; 10. patients who have used flu vaccine in recent 12 months before took part in this trail; 11. patients who have used any influenza drug before saw a doctor.

Design outcomes

Primary

MeasureTime frame
Time of temperature to nomal;

Secondary

MeasureTime frame
body temperature return to normal time;Effects of influenza;Effects of TCM symptoms;Effects of single symptom;Disease outcome;The number of antipyretic analgesic;

Countries

China

Contacts

Public ContactSun Zengtao

2nd accessary hospital of Tianjin University of Traditional Chinese Medicine

tjgcp@126.com+86 022 60335308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026